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plantation will probably occur after intermediate-term 
preservation has been successfully accomplished, as 
only then will the more time-consuming methods of 
donor-recipient matching, such as mixed lymphocyte 
culture, be practical. In addition, it would be an enor-
mous advantage if kidneys could be stored for the same 
period of time that blood is stored now. 
Long-Term Preservation 
Long-term preservation awaits a breakthrough in 
freezing of whole organs at temperatures below -7g' C. 
The problems involved in freezing large organs, such as 
the human or dog kidney, are enormous. So far, there 
have been no published reports that such organs have 
been actually frozen for any length of time, thawed, 
and successfully implanted. Although this may become 
the procedure of choice in the distant future, this 
method probably depends upon the development of a 
nontoxic cryoprotective agent that will remain in liq-
uid form at much lower temperatures than are current-
ly possible. If such a cryoprotective agent can be found, 
the problems of uneven freezing and thawing of large 
organs could be solved. 
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LIVER HOMOTRANSPLANTATION 
Thomas E. Starzl, M.D., Ph.D., and Lawrence Koep, M.D. 
The liver has far more complicated metabolism than 
other transplanted organs, and its malfunction leads to 
vastly more complex physiologic derangements. Pa-
tients with liver disease are further handicapped by the 
lack of a satisfactory means of artificial support compa-
rable to renal dialysis. The transplanted liver must 
function efficiently practically from the moment of 
anastomosis or the patient is lost. Despite these and 
other difficulties, there has been enough progress to 
state that liver transplantation may in certain cases be 
considered the treatment of choice. Human survivals of 
up to 9 2/3 years have been achieved. 
KINDS OF LIVER TRANSPLANTATION 
There are two general approaches to transplantation 
of the liver. With the first method, the host liver is 
removed and replaced with a homograft (orthotopic 
homotransplantation) (Fig. 1). The alternative tech-
nique is the insertion of an extra liver (auxiliary 
homotransplantation) at an ectopic site (Fig. 2). Both 
procedures were developed in dogs and later studied in 
other species, including rats, pigs, monkeys, and 
humans. The most encouraging results have been with 
orthotopic transplantation, for which reason this chap-
ter will be concerned primarily with this replacement 
operation. However, in a special section near the end of 
the chapter, auxiliary hepatic transplantation will be 
briefly considered. 
IMMUNOLOGIC CONSIDERATIONS 
Is the Liver a Privileged Graft? 
When liver replacement was first successfully per-
formed in dogs, immunosuppression was stopped after 
4 months. A surprising number of animals continued to 
thrive either with no signs of rejection or with rejection 
episodes that waxed and waned remittently.3 One such 
dog lived in our laboratory for more than 11 years after 
transplantation. This phenomenon of "graft accept-
ance" has been noted in dogs with renal transplants, 
although less frequently. The seeming immunologic 
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Figure 1. Completed orthotopic liver transplantation (liver re-
placement)_ 
advantage of the liver has been even more clearly seen 
in pigs, some of which can survive chronically with no 
immunosuppressive therapy at alP, 3 in spite of the fact 
that pigs regularly reject skin and kidney grafts. The 
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Figure 2. Auxiliary liver transplantation with a technique that 
provides an adequate blood supply for the homograft. Note that the 
transplant is given a double blood supply and that the venous com-
ponent is from the nonhepatic splanchnic bed. Biliary drainage can 
be with a Roux-en-Y cholecystojejunostomy. 
reason for easier liver graft acceptance is not known. 
Whatever the explanation, overstatement of the case 
for the liver's privileged status could lead to erroneous 
conclusions about the practical requirements for im-
munosuppressive therapy following hepatic transplan-
tation in man. In humans, control of hepatic rejection 
may be difficult or impossible in spite of very heavy 
immunosuppressive therapy. 
Rejection Reversal 
Rather than being unique, it is probable that liver 
homo grafts differ from other organs only by the degree 
of host immunologic response they evoke in all species, 
including the pig. In this context, two key observations 
initially made with kidneys have been extended to the 
liver. The first is the reversibility of rejection. Reversal 
usually requires intensification of treatment, but it has 
sometimes been noted without any change in the pre-
existing therapy, suggesting that such recoveries had 
an element of spontaneity. 
Graft Acceptance 
The second observation of overriding practical and 
theoretical interest concerns what has already been 
referred to as graft acceptance. In many of the human 
kidney and liver recipients treated years ago,3. 4 it was 
shown that a melting away of host resistance to the 
homograft occurred surprisingly early after transplan-
tation, sometimes following an acute rejection crisis. 
This was manifested by eventual declines in the doses 
of immunosuppressive agents necessary to retain 
stable graft function. In many patients, the level of 
chronic immunosuppression has proved to be less than 
that which at the outset failed to prevent the onset of a 
severe rejection. The ultimate step of cessation of all 
treatment has been too dangerous to attempt. 
Explanations for Graft Acceptance 
The degree to which graft acceptance develops is a 
prime determinant of the long-term prognosis. Unfor-
tunately, the reason for the change in the host-graft 
relationship is not known. More than one immunologic 
pathway may be involved. 
IMMUNOLOGIC TOLERANCE. One possibility is 
that there is a selective loss of responsiveness to anti-
gens. It might be envisioned that specific lymphocyte 
clones, induced to replicate by the graft antigens, are 
thereby rendered more vulnerable t~ the killing effect of 
immunosuppressive agents than the rest of the lympho-
cyte population (Fig. 3). Inasmuch as the maintenance 
of such activated cell lines appears to be thymus-
dependent even in adult life, at least in some experi-
mental animals, it is reasonable to be curious about the 
effect of thymectomy as an adjuvant immunosuppres-
sive measure. The results of thymectomy in a series of 
our human renal transplants were inconclusive.3 
The concept of specific, differential tolerance through 
"clone stripping" can partly explain the characteristic 
cycle of rejection and reversal occurring after whole-
organ transplantation both in treated animals and in 
man as well as in the weak and self-resolving crises in 
the untreated pig. Moreover, it is consistent with the 
fact that a wide variety of agents that are capable of 
general immunologic crippling can also provide speci-
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Figure 3. Hypothetical mechanisms by which 
nonspecific immunosuppression may lead to selec-
tive abrogation of the host immune response. 
Special susceptibility to these agents of a fraction 
of the lymphoid population could lead to exhaus-
tion of a clone, and hence, tolerance. Since main-
tenance of such cell lines even in adult life is appar-
ently thymic-dependent in experimental animals. 
thymectomy would be expected to aid the process; 
this appears to be true in rodents. but such an ef-
fect of thymus removal has not been proved in 
dogs or humans. A possible protective role of im-
munoglobulins elaborated by the replicating cells 
is also shown. 
" . ~ 
,,/:H <ioco 
ivmDh"yI~~D;::::lDhD;::~ \ 
• • ,-I--, r---L--, (fI • @) ~~ • 
-------, ...... ----------~ ----------
I mmu ne .... ________ ~ _"K<:D:c:~D""KI ....... "'>- --- - --> 
.... ---------~ -------> 
Suppression ~- - - - - - - - -> \- - - - - -> 
------' .... ------- - -> . + ------> 
ficity of action under the stipulated conditions of im-
munosuppressive treatment during presence of the 
antigen. However, classic immunologic tolerance can-
not be demonstrated in most patients who have chron-
ically functioning whole-organ grafts. 
ENHANCEMENT. These ambivalent findings do 
not disprove tolerance through "clone stripping" so 
much as they suggest that at least another mechanism 
of graft acceptance may be involved. One such mecha-
nism, termed "enhancement," has been envisioned as a 
process in which immunoglobulins synthesized by the 
activated lymphoid tissues circulate to the target tissue 
and coat it or protect it in some way that is not yet 
understood (see Fig. 3). 
The two foregoing mechanisms of graft acceptance by 
tolerance induction and enhancement are not mutually 
exclusive. Using immunologic monitoring tests, a 
number of investigators have demonstrated changing 
host-graft relationships in kidney recipients that are 
consistent with a multifactorial graft acceptance hy-
pothesis. 
TISSUE TYPING 
In kidney transplantation, standard HL-A typing 
has not been a precise method of selecting biologically 
suitable donors. Even if these techniques were more 
reliable, it is unlikely that seeking well-matched livers 
would be possible. The need for transplantation has 
been so pressing in appropriate candidates that it often 
has been obligatory to proceed with the first available 
organ. Thus, almost all of the matches in our series 
have been bad ones.4 
Because of urgent needs, ten liver transplantations 
have been performed despite the presence in the recipi-
ents of cytotoxic antibodies that were antidonor-
specific. In addition, we have proceeded in 11 liver 
recipients who could not wait for blood group-compati-
ble organs. There were no unequivocal examples of the 
hyperacute rejection that almost invariably destroys 
Immunoglobulins 
renal homografts under these adverse immunologic 
circumstances. We4 as well as CaIne and Williamsl 
have concluded that the liver is highly privileged, at 
least in confrontations with a preformed antibody envi-
ronment. Nevertheless, transplantation into a hostile 
antibody environment is a violation of such an impor-
tant biologic principle that it will require constant 
reassessment as more experience is acquired. 
THE PROCUREMENT OF ORGANS 
In contrast to typing, the procurement of a fresh, 
functioning, nonischemic liver is of paramount advan-
tage. 
The Source of Donors 
Unquestionably, one of the most important advances 
that has been made in transplantation has been social 
in nature, namely acceptance by the public of the 
concept of cadaveric organ removal. The interval of 
normothermic ischemic injury was virtually eliminat-
ed, since the organ usually could be dissected free in 
the presence of an intact and effective circulation. 
Suitable donors usually are victims of head trauma or 
of asphyxia that has caused irreversible brain dam-
age. 
Preservation Techniques 
The subsequent preservation of the liver is also of 
vital importance and has been accomplished by one or 
more preservation modalities, depending on circum-
stances and always including organ hypothermia.3 
After removal, quick cooling may be accomplished by 
running a chilled electrolyte solution through the por-
tal vein, thus lowering the donor organ temperature to 
about 10 or 15°C., which is sufficient for adequate 
preservation during the hour or two required for the 
vascular anastomoses in the recipient. 
Since 1976, methods have been available that permit 
relatively safe and simple storage for longer periods. 
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The Cambridge-King's College team has used a plasma 
solution for cold infusion of the homografts,' and we 
have employed an electrolyte (Collins') solution with a 
composition similar to that found in cells.4 In dogs, the 
two approaches yield comparable results and permit 
safe preservation for up to 12 hours. The same applies 
to humans and has permitted the shipment of livers 
from city to city. The Cambridge surgeons' have cau-
tioned that ischemia or bile left within the ducts or 
both within such livers may cause autolysis and set the 
stage for delayed mucosal sloughing and cast forma-
tion. 
Despite the advantages afforded by brain-dead 
donors and the improvements in preservation, hope-
lessly damaged organs are still occasionally trans-
planted. There is at present no reliable way to prevent 
such tragedies by any practical test for homograft via-
bility. 
SURGICAL TECHNIQUES OF ORTHOTOPIC 
TRANSPLANTATION 
A Species Difference 
With removal of the host liver it is necessary to 
cross-clamp temporarily the great veins draining the 
intestines (portal vein) and the lower half of the body 
(inferior vena cava). Dogs die promptly if the distal 
venous pools are not decompressed.3 In contrast, 
humans with liver disease have tolerated this venous 
obstruction surprisingly well. Although a slight duski-
ness of the intestine developed in some recipients, it 
immediately disappeared when blood flow was restored 
through the reconstructed venous channels. The ease 
with which portal and vena caval cross-clampingwas 
tolerated can be explained by man's inherently richer 
network of potential collateral channels for the return 
of blood to the right heart, and by, the presumed 
increase in their size and ramifications in consequence 
of the underlying liver disease.3 
Hemorrhage 
Other problems during and after operation may be 
caused by derangements in the coagulation mechanism 
which may result in either hemorrhage or thrombosis.3 
The nature of the underlying hepatic pathologic pro-
cess produces portal hypertension in nearly every pa-
tient, and the nature of the operation tends to exagger-
ate it. The usual consequence is mechanical bleeding 
that can rapidly assume nightmare proportions during 
the procedure. Many of the normal coagulation factors 
that might help control hemorrhage are dependent on 
the liver and are therefore defective. If the homograft 
does not function properly, hemostasis may be impossi-
ble to achieve. 
When hemorrhage occurs, the surgeon's challenge is 
to use all available hemostatic tactics -ligatures, su-
tures, and cautery - until the revascularized homo-
graft can participate in what is hoped will be appro-
priate coagulation function. With our earlier patients, 
whose homografts were often of less than optimal 
quality, an attempt was made to treat bleeding prob-
lems by administering thrombogenic agents. However, 
hypercoagulability was caused in some instances. The 
unacceptable incidence of pulmonary embolism in 
these patients led us to abandon this approach. Later 
the bleeding may be succeeded by complications of 
heightened clotting. Ironically, the better the condition 
of the transplant, the greater the risk of unwanted 
coagulation. Almost every series of liver transplants 
including our own, has had examples of thrombosis. ' 
In general, it is now considered best to avoid iat-
rogenic manipulation of the clotting process with 
either thrombogenic or anticoagulant agents. Instead 
our current approach is to leave correction of coagula: 
tion abnormalities to natural processes, intervening 
only under special circumstances and for very specific 
indications. 
Air Emboli 
Eventually lethal neurologic invalidism was seen in 
9 of the first 48 adult patients undergoing liver replace-
ment. The complications occurred during or shortly 
after operation. Several of these patients awakened 
from anesthesia but then had a secondary decrease in 
consciousness, seizures, and other crippling abnormali-
ties. They died within a few days to 2 months. It 
ultimately was realized that air emboli from the homo-
grafts were responsible for some, if not all, of the focal 
infarctions.4 The ease with which air passed to the 
systemic circulation was explicable by the right-to-left 
venous-arterial shunts that are common in chronic 
liver disease. Air released into the pulmonary circula-
tion apparently passed through these collaterals to the 
systemic circulation, including the arterial supply to 
the brain. 
Suprahepatic anastomosis 
A 
Low molecular wei9ht 
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c 
.Figure 4. TeChnique to prevent air embolism from orthotopic 
liver homografts. A, Continuous perfusion of solution through the 
portal vein as vena caval anastomoses are constructed. Band C, 
Escape of air bubbles as the anastomoses are completed. (From 
Starzl, T.E. et al.: Ann. Surg., 187:236-240, 1978.) 
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With the delineation of this cause for the neurologic 
complications, measures were instituted to prevent it. 
During revascularization of the liver, electrolyte solu-
tion was slowly infused through a portal vein cannula. 
While the vena caval anastomoses were carried out, air 
bubbles could escape from the graft vessels before a 
blood supply was restored (Fig. 4). Since the institution 
of this simple preventive measure no further such 
difficulty has been encountered. 
Vascular Anomalies 
In planning a liver transplantation, the surgeon 
must be prepared for a high incidence of anatomic 
variations in either the graft or the host structures.3 
These have been encountered in almost 40 per cent of 
our cases. Multiple arteries have been the most fre-
quent anomalies. When these have been in the recipi-
ent, most commonly the graft celiac axis has been 
connected to the host celiac axis. When the mUltiplicity 
has occurred in the transplant vessels, it usually has 
been possible to trace these back to their celiac axis 
origin and to perform a single anastomosis of the graft 
celiac axis to the recipient proper or to a common 
hepatic artery. However, multiple arterial anasto-
moses or other variant procedures have been used. The 
need to improvise in these situations imposes an extra 
risk, particularly in very young recipients whose arte-
ries are quite small and thin-walled even under the 
best technical circumstances. 
Biliary Tract Problems 
Realization that the biliary tract was of prime impor-
tance in liver transplantation prompted major reforms 
both at our center and in England. Until 1976, we 
commonly performed cholecystoduodenostomy (Fig. 
5A). Although the operation was simple, obstruction or 
bile fistula formation occurred in 30 percent of the 
patients, almost always leading to death.4 Further-
more, homo grafts seemingly were subjected to repeated 
bacterial contamination, with resulting cholangitis 
and consequent systemic infection. We now believe 
that the ideal method of biliary reconstruction is chole-
dochocholedochostomy, using aT-tube stent (Fig. 5D) 
which is left in place for many months. After the T-tube 
is removed, periodic retrograde cholangiography via 
the duodenum can be performed in such recipients. 
Choledochocholedochostomy often is not feasible, as, 
for example, in children with biliary atresia. As alter-
natives we perform cholecystojejunostomy (Fig. 58) or 
choledochojejunostomy (Fig. 5C) to a Roux limb of 
jejunum. In immunosuppressed patients the initial 
construction of the Roux limb has carried an intrinsic 
risk, in that perforations of the Roux limb itself or the 
jejunojejunostomy below it occurred in 8 patients 
among the first 141. Seven of the eight patients died 
from this complication. 
The advantage of cholecystojejunostomy is that a 
large-caliber anastomosis is possible, even with the use 
of pediatric livers. No stenting or draining is necessary. 
The disadvantage is that obstruction of the cystic duct 
(Fig. 6) has necessitated reoperation and conversion to 
choledochojejunostomy (see Fig. 58 and C) in almost 
one third of the cases. However, the secondary proce-
dure has been safe. CaIne and Williams have advocated 
B Jejunum 
T-Iube in reCIpient D common duct 
Figure 5. Techniques of biliary duct reconstruction used for most 
liver transplant recipients. A. Cholecystoduodenostomy. S, Chole-
cystojejunostomy. C, Choledochojejunostomy after removal of gall-
bladder. D, Choledochocholedochostomy. Note that T-tube is placed if 
possible in the recipient common duct. (From Starzl. T.E. et al.: 
Surg. Gynecol. o bstet. , 142:487. 1976.) 
a different surgical approach.l With Calne's technique, 
the common duct and gallbladder are connected into a 
common chamber, and a second anastomosis of the 
gallbladder fundus is made to the recipient common 
duct (or sometimes to a Roux limb). The cholecys-
tocholedochostomy is stented with a T-tube, enabling 
the biliary system to be frequently studied or irrigated. 
Experience alone will tell if CaIne's more complicated 
reconstruction is necessary or desirable. 
In the postoperative management of liver transplan-
tation, the possibility of duct obstruction must be 
entertained no matter what the method of reconstruc-
tion. Until the last few years, postoperative hepatic 
dysfunction was too readily ascribed to rejection, when, 
in fact, obstruction or cholangitis or Qotlh were fre-
quently responsible. Even in the absence of a biliary 
tract problem, rejection may not be responsible. Hepa-
titis caused by HBsAg, CMV, and other viruses has 
been observed as well as drug toxicity. At the present 
time, the development of jaundice after transplantation 
is a signal for cholangiography and usually for liver 
biopsy. The histopathologic findings in the biopsy tis-
sue may not provide an unequivocal answer. Then, the 
diagnosis of rejection must be made by exclusion. 
Anesthesia 
During operation, there are metabolic abnormalities 
other than those concerned with coagulation. These 
contribute to the complexity of anesthetic manage-
ment. Not only is the procedure long and difficult, but 
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even more important, it is an operation on the prima-
ry organ involved in the metabolism and detoxification 
of most common anesthetics. At any point during the 
operation, the liver is either inherently impaired, ab-
sent, or untried in its new setting. Hence, the task of 
the anesthesiologist is to administer correctly drugs 
that, first, are not hepatotoxic and, second, do not 
depend primarily on the liver for their degradation. In 
our cases, reliance has been placed mainly on combina-
tions of volatile agents in nonexplosive concentrations. 
Such management permits use of the electrocautery, 
gives flexibility in lightening or deepening anesthesia, 
and allows anesthesia to be abruptly stopped if re-
quired by changing physiologic circumstances. Further 
Figure 6. Examples revealed by transhepatic cholangiography 01 homogralt cystic duct obstruction alter biliary reconstruction with chola-
cystoenterostomy. A, Original procedure was cholecystoduodenostomy. Alter this trans hepatic cholangiogram. conversion was made to chola-
dochoduodenostomy. At operation . the fitt ing defect near the exit of the cystic duct was found to consist of a chalk-like sludge. There was not 
complete relief of jaundice. When the patient died 13 months after transplantation. the homograft stitt had Intrahepatic evidence of large duct 
obstruction. B, The original reconstruction was with cholecysto-Roux-en-Y jejunostomy. This was converted to a choledochojelunostomy. The 
patient is wett 5 years later. C, The original reconstruction was with cholecysto-Roux-en-Y jejunostomy. This was converted to a choledocho-
jejunostomy. The patient Is wett 52{, years later. CO = common bile duct ; CyO = cystic duct; GB = gallbladder; J = Roux-en-Y limb of jejunum. 
(From Starzl. T.E. et al. ; Surg. Gynecol. Obste!.. 142;487-505. 1976.) 
., 
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details of operative technique and complications can be 
found in the appropriate references. I. 3. 4 
IMMUNOSUPPRESSION 
The immunosuppressive therapy in liver transplan-
tation has borrowed heavily from the experience 
gained with human renal transplants. Two general 
treatment programs were developed with the simpler 
kidney model and later applied to the liver recipients. 
The first protocol, which was used from 1962 to 1966 
for all organ recipients at the University of Colorado, 
consisted of"double-drug" treatment with azathioprine 
and the synthetic adrenal cortical steroid prednisone.3 
Experience with the combined use of these agents, 
appreciation of their marked synergism, and demon-
stration that rejection could be readily reversed by 
increasing the steroid doses were among the advances 
that made clinical transplantation practical. But in 
spite of fair results with renal transplantation, the 
double-drug therapy either did not prevent rejection of 
hepatic homo grafts or else proved too toxic to permit 
host survival. Six patients treated with liver transplan-
tation from 1963 to 1965 died in a month or less. The 
double-drug regi:men is still used by the Cambridge 
team.' 
In 1966, heterologous antilymphocyte serum (ALG) 
was introduced clinically at our center as a third 
immunosuppressive agent in addition to the drugs 
mentioned previously.3 Almost all of our human liver 
recipients who achieved long-term survival were treat-
ed with the combination of azathioprine, prednisone, 
SGOT 
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and intramuscular ALG (Fig. 7). In the event of a 
rejection episode, it is the steroid component that is 
most amenable to quick adjustment of dosage according 
to need. When hepatotoxicity of azathioprine is sus-
pected, the alkylating agent cyclophosphamide, which 
has immunosuppressive qualities equivalent to those of 
azathioprine, may be substituted.4 
Thoracic Duct Fistula 
Recently there has been revitalized interest in thora-
cic duct fistula as an immunosuppressive adjunct.· 
With this procedure, lymphocytes are mechanically 
removed from the cervical thoracic duct lymph with 
reinfusion of the cell-free lymph. In cadaveric kidney 
recipients, pretreatment by this method for at least 3 
weeks and preferably longer has had such a profoundly 
immunosuppressive effect that irreversible early rejec-
tion after transplantation has been almost eliminated. 
The patients require postoperative therapy with azathi-
oprine (or cyclophosphamide) and prednisone. Whether 
this advance can be applied to liver transplantation, 
however, remains to be seen. 
Complications of Immunosuppression 
RISKS WITH ALL ORGANS. The most obvious 
penalty of a depressed immune system is heightened 
susceptibility to infection. It has also become obvious 
that chronically immunosuppressed patients have an 
increased vulnerability to de novo malignancies.3 This 
complication is presumably due to failure of the de-
pressed immunologic surveillance mechanism to iden-
tify the tumor tissues as alien and to eliminate them or 
restrict their growth. 
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Figure 7. A 5-year-old child (OT 19) with intrahepatic biliary atresia who was treated with orthotopic liver transplantation. A very transient 
rejection occurred after 1 month. This underwent almost immediate and complete remission. A late rejection. which began on postoperative 
day 72, was easily controlled. Note the change in time after 4 months. The patient had stable liver function for 39 months before dying a few 
weeks after a bout of Hemophilus influenza. Our current practice is to limit ALG to a few weeks instead of the long course depicted. 
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EXTRA RISKS FOR LIVER RECIPIENTS. There 
are some special risks for the candidate for liver trans-
plantation. One is the fact that hepatic injury in all 
kinds of organ recipients has commonly been produced 
by the agents, individually or in combination, of the 
therapeutic regimen.3 • 4 In some instances, viral hepati-
tis, apparently made chronic by the partial immunologic 
invalidism of the host, has been a plausible explanation. 
In others, hepatotoxicity of the drugs was probably 
responsible. With liver malfunction, dose control of· 
some of the agents may become difficult, since the 
liver participates in their pathways of action or deg-
radation. These hepatic factors are obviously import-
ant in any situation requiring immunosuppression, 
but they have heightened significance for a trauma-
tized liver transplanted to a new and hostile environ-
ment. 
It was mentioned earlier that infection was a major 
risk to any immunosuppressed patient. In the liver 
recipient, postoperative sepsis of the graft itself has 
proved to be a special problem, without doubt partly 
because of the anatomic location of the orthotopically 
placed organ, interposed between the intestinal tract 
and the heart. Bacteria from the bowel, particularly of 
the gram-negative variety, can be brought into contact 
with the transplanted liver via the intestinal veins 
draining into the portal vein or, far more importantly, 
by retrograde spread up the duct system after passage 
through the biliary anastomosis. In either event, the 
presence of nonviable hepatic tissues provides a perfect 
medium for bacterial growth. Eventually, abscesses or 
partial gangrene of the transplant can result, with 
characteristic nonvisualizing areas on the liver scans, 
gram-negative bacteremia, and all the findings of gen-
eralized sepsis. 
A VOIDANCE OF HOMOGRAFT SEPSIS. Anti-
biotics are given for the first several postoperative 
days, after which therapy is stopped. Our prophylactic 
protocol includes agents effective against gram-
negative bacteria. The most important step in reducing 
hemograft sepsis has been to use biliary reconstructive 
techniques that prevent systematic contamination by 
gastrointestinal contents (see Fig. 5B, C, and D). 
INDICATIONS FOR LIVER REPLACEMENT 
The first human orthotopic liver transplantation was 
performed in March 1963. Between then and December 
1977, a total of 141 consecutive patients were treated 
with this operation with potential follow-up now for all 
survivors of 1 112 years. The indications are shown in 
Table 1. 
Infants and Children 
The indications for operation were wide ranging. 
Patients below 18 years of age accounted for more than 
half of our first 141 recipients (74 in all). Within this 
pediatric group there were 48 examples of biliary 
atresia. The other indications for liver replacement in 
our pediatric series accurately reflect our present atti-
tude toward appropriate case selection, with the excep-
tion of primary hepatic malignancy. All three children 
whose reason for operation was hepatoma developed 
recurrences within a few months. However, our longest 
postoperative survivor (9 2/3 years) has been cured of 
an incidental hepatoma in her excised biliary atretic 
liver. A small hepatoblastoma was found in the liver of 
another child with alpha I-antitrypsin deficiency who is 
tumor-free 1 2/3 years later. Thus, the extent of the 
malignancy would seem to be a prime factor in surviv-
al. 
It has become clear that manifestations of liver-
based inborn errors of metabolism can be cured with 
liver replacement. We have had experience with Wil-
son's disease, alpha I-antitrypsin deficiency, tyrosi-
nemia, and Type IV glycogen disease (alpha-glycosidase 
deficiency). The metabolic abnormalities in all these pa-
tients were corrected. Other indications in children 
have included chronic aggressive hepatitis and neona-
tal hepatitis. 
TABLE 1. Indications for Orthotopic Liver Transplantation at the U Diversity of Colorado 
Number 
Diagnosis of Cases Lived> 1 Year 
Biliary atresia 48 
Chronic aggressive hepatitis 36* 
Primary liver malignancy 19 
Alcoholic cirrhosis 15 
Alpha1-antitrypsin deficiency 5 
Primary biliary cirrhosis 5 
Sclerosing cholangitis 4 
Secondary biliary cirrhosis 2 
Wilson's disease 2 
Massive hepatic necrosis (B virus) 1 
Congenital biliary cirrhosist 1 
Budd-Chiari syndrome 1 
Congenital tyrosinemia 1 
Type IV glycogen storage disease 1 
Total 141 
*Two had neonatal hepatitis and were treated at ages 7 112 and 30 years. 
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Adults 
Sixteen liver transplantations were carried out to 
treat nonresectable hepatomas, duct cell carcinomas 
angiosarcoma, and cholangiocarcinoma. Seven of the~ 
recipients lived beyond 3 months, and six of them later 
developed metastases. Similarly, the recurrence rate in 
the Cambridge-King's College series in England has 
been 70 percent.! As more such cases have been docu-
mented, we have had decreasing enthusiasm for and 
indeed have usually avoided, transplantation fo; ma-
lignancy. Still, there is no denying that some patients 
with malignancy have benefited from liver replace-
ment. Three of our adult patients lived for more than 2 
years in spite of recurrences, and two are still alive 
after 2 213 and almost 5 years. 
Less questionable reasons for liver transplantation 
in adults are included in Table 1. In the future, the 
leading indications undoubtedly will be chronic aggres-
sive hepatitis and Laennec's cirrhosis. The presence of 
HBsAg viremia is not a contraindication, since effective 
postoperative treatment can be given with hyperim-
mune serum.1• 4 Cases of cirrhosis pose a supreme 
tec~ical chl~KllengeK If results are to be improved, 
candidates wIll need to be selected at an earlier time. 
Too often in the past the recipients have been moribund 
by the time of operation. 
. There is. little. point in exhaustively discussing 
different lIver diseases in connection with trans-
plantation, since anyone with end-stage liver disease 
theoretically might be a candidate. Relative con-
traindications include advanced age (beyond 50 years) 
and infections. Judgment must be exercised not to 
proceed too early in the natural history of the pa-
tient's disease and not to make the equally or more 
serious error of waiting too long. 
RESULTS 
aurin~the 13.years from May 1963 to July 1976, 111 
consecutive patIents underwent attempted liver re-
placement - 50 adult and 61 pediatric recipients. Of 
the 111 patients, only 31 (28 percent) lived for as long 
as 1 year (Table 2). Ten of the I-year survivals were 
among the 50 adult patients, and 21 were among the 61 
pediatric patients. 
After 1 year, 17 of the 31 patients who were alive at 
the I-year mark died after total survival periods of 1 to 
6 years. The most common reasons for late death were 
chronic rejection, uncorrected biliary obstruction, sys-
temic infection, and recurrent malignancy, in that 
order.4 
Fourteen of the patients included in the 1963-1976 
series are still alive with follow-ups that now range 
from 3 213 to 9 213 years. These patients have had a 
very high order of rehabilitation. The adults and ado-
lescents have all returned to school or work and the 
infants have entered and done well in school: 
Another 30 patients (Table 2) were treated from July 
1976 to December 1977, using the technical, diagnostic, 
and management improvements mentioned earlier. 
There were 17 adults and 13 infants or children. The 
I-year survival in this group was 15 of 30 (50 per cent) 
including 7 of the 17 adults and 8 of the 13 pediatri~ 
recipients. Two late deaths occurred, one at 16 1/2 
months because of portal vein thrombosis, and the 
other at 23 months because of systemic chickenpox. 
The other 13 patients were still alive after 1213 to 31/3 
years. 
Future Prospects 
It had been hoped that the results would even-
tually become acceptable, with better technical perfor-
mance, more discriminating case selection, and shar-
pening of criteria for the differential diagnosis of 
postoperative hepatic malfunction. Such optimistic ex-
pectations have been only partly realized. Although the 
I-year surviv~rship gradually rose to 50 per cent, it has 
not been pOSSIble to improve these figures. During the 
last year and a half, 23 more patients were treated. The 
probability is that only six of these will live for as long 
as 1 year .. The combination of such a complex technical 
unde~mg and t~e handicap of unsafe immunosup-
preSSIOn has remaIned too formidable for consistent 
success. 
qh~ pro~pect of safer and more effective immunosup-
preSSlOn IS currently in sight. Possibilities include 
better drug treatment, especially with the fungus ex-
tract cyclosporin A, which is receiving its first clinical 
trials in renal recipients. Total lymphoid irradiation is 
a. prom~sing b~t less well developed immunosuppres-
SIve adjunct. Fmally, there is evidence in human kid-
n~y recipients, as mentioned earlier, that pretreatment 
WIth thor~cic .duct drainage (TDD) can more effectively 
control reJectIon, resulting in less morbidity and mor-
tality. 
The applicability of any of these methods in liver 
TABLE 2. Survival in the Early and Late Phases of the Colorado Experience 
(Follow-up to September 1979) 
Total Lived> 1 Year Alive Now 
Series I 111* 31 (28%) 14 (after 3 2/3 to 9 2/3 years):!:; 
(March 1963-July 1976) 
Series II 30t 15 (50%) 13 (after 1 2/3 to 3 112 years)§ 
(August 1976-December 1977) 
*t~th pat~ents s 18 years of age, the I-year survival was 21161 (34%). Among adults, survival was 10/50 (20%) 
.tWlth patients s 18 years of age, the I-year survival was 8/13 (62%). Among adults, I-year survival was 7/17 (41%) 
tThe 17 late deaths were after 1 to 6 years. . 
§One late death was at 23 months and the other after 16 1/2 months. 
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transplant recipients remains to be established. The 
ideal will be a form of treatment so effective and so safe 
that hepatic malfunction postoperatively can auto-
matically be ascribed to factors other than rejection. 
Until this can be achieved, liver transplantation will 
remain a heroic form of therapy with limited ap-
plicability. 
AUXILIARY LIVER TRANSPLANTATION 
The alternative to hepatic replacement is to leave the 
native liver in place and to transplant an extra liver 
which is in some ectopic site, such as the splenic bed, 
the right or left paravertebral gutter (see Fig. 2), or the 
pelvis. The main theoretical advantage of auxiliary 
transplantation is that the recipient is not at the outset 
placed totally at the mercy of homograft function. A 
second possible advantage would be avoidance of the 
technical hazards of recipient hepatectomy. 
By May 1969, nine clinical attempts had been made, 
four at the University of Colorado and one each at five 
other institutions.3 The longest survival was 35 days. 
Of the many problems encountered, not the least was 
difficulty in finding room for an extra organ in an 
already overcrowded abdomen. In addition, it had been 
learned from animal studies that the optimal condition 
for the transplanted liver was portal venous inflow of 
splanchnic venous blood which contains specific hepa-
totrophic substances (especially endogenous insulin).5 
Fortner and associates of New York have maintained 
an interest in auxiliary transplantation, and in Sep-
tember 1978 they summarized their results as well as 
those obtained elsewhere.2 By that time, they had 
information on 43 cases, including 7 of their own. There 
was one unqualified success, a patient with biliary 
atresia who was alive 5 1/2 years postoperatively. The 
other recipients died early from a variety of complica-
tions. . 
Our view is that auxiliary transplantation should be 
reserved for patients with acute hepatic disease in 
whom the objective is temporary life support while 
recovery of the native liver can be obtained. The 
feasibility of this approach has been proved in several 
animal studies but not yet in humans. 
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